首页> 美国卫生研究院文献>Marine Drugs >Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives
【2h】

Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives

机译:来自深海微生物的抗生素:最新发现和观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing emergence of new forms of multidrug resistance among human pathogenic bacteria, coupled with the consequent increase of infectious diseases, urgently requires the discovery and development of novel antimicrobial drugs with new modes of action. Most of the antibiotics currently available on the market were obtained from terrestrial organisms or derived semisynthetically from fermentation products. The isolation of microorganisms from previously unexplored habitats may lead to the discovery of lead structures with antibiotic activity. The deep-sea environment is a unique habitat, and deep-sea microorganisms, because of their adaptation to this extreme environment, have the potential to produce novel secondary metabolites with potent biological activities. This review covers novel antibiotics isolated from deep-sea microorganisms. The chemical classes of the compounds, their bioactivities, and the sources of organisms are outlined. Furthermore, the authors report recent advances in techniques and strategies for the exploitation of deep-sea microorganisms.
机译:人类致病细菌中新形式的多药耐药性的不断出现,以及随之而来的传染病的增加,迫切需要发现和开发具有新作用方式的新型抗菌药物。当前市场上可获得的大多数抗生素是从陆地生物获得的或半合成地从发酵产物获得的。从先前未开发的栖息地中分离出微生物可能会导致发现具有抗生素活性的铅结构。深海环境是一个独特的栖息地,深海微生物由于适应这种极端环境而具有产生具有强大生物活性的新型次生代谢产物的潜力。这篇综述涵盖了从深海微生物中分离出来的新型抗生素。概述了化合物的化学类别,其生物活性和生物来源。此外,作者报告了深海微生物开发技术和策略方面的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号